EB-701

N/A

Report date: 2026/04/27 11:22:20

Base Information

Drug NameEB-701

Drug Alias NameEB-701

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionCD70 antigen modulatorsCarbonic anhydrase IX modulatorsNatural killer cell replacements

TargetsCD70 antigenCarbonic anhydrase IX

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusN/A

Highest Status in ChinaN/A

Originator CompaniesBeijing Biotech

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A